Archive for 'Discoveries and Innovations'

Depression treatment can help diabetes patients

Depression treatment can help diabetes patients

Posted on28. Apr, 2011 by .

0

Many diabetics also suffer from depression. A study released in April shows treating depression in consumers with type 2 diabetes can bring benefits to their overall health. Scientists at the Ann Arbor Healthcare System and the University of Michigan Health System showed that addressing depression in consumers with diabetes’ improved health, including reduction in depression […]

Continue Reading

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Posted on05. Nov, 2010 by .

0

Most Patients Have Self-Doubt; CBT May Help By Icelini Garcia-Sosa, MD and Michael Garrett, MD Psychiatric Times | October 29, 2010 http://www.psychiatrictimes.com/schizophrenia/content/article/10168/1708863  Summary Most delusional patients, even those with high positive symptom scores, may have at least 1 Reason for Doubt (RFD) that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands […]

Continue Reading

UAB study documents connection between depression and abdominal obesity

UAB study documents connection between depression and abdominal obesity

Posted on22. Jul, 2010 by .

0

June 9, 2010 BIRMINGHAM, Ala. – A new study at the University of Alabama at Birmingham (UAB) confirms the relationship between depression and abdominal obesity, which has also been linked to an increased risk for cancer and cardiovascular disease. “We found that in a sample of young adults during a 15-year period, those who started […]

Continue Reading

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Posted on03. Jun, 2010 by .

0

Wijnand Laan, PhD; Diederick E. Grobbee, MD, PhD; Jean-Paul Selten, MD, PhD; Cobi J. Heijnen, PhD; René S. Kahn, MD, PhD; and Huibert Burger, MD, PhD  http://article.psychiatrist.com/dao_1-login.asp?ID=10006874&RSID=40173234257663  J Clin Psychiatry 2010;71(5):520–527 10.4088/JCP.09m05117yel  © Copyright 2010 Physicians Postgraduate Press, Inc.  Objective: Inflammatory processes may play a role in the pathophysiology of schizophrenia. The aim of this […]

Continue Reading